[Pagetoid lymphoma of the Ketron-Goodman type].
Royer
P
P
Service de Dermatologie, Hôpital Henri-Mondor, Université Paris XII, Créteil.
Bagot
M
M
Wechsler
J
J
Roujeau
J C
JC
Fraitag
S
S
Revuz
J
J
D000328:Adult; D015703:Antigens, CD / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D010641:Phenotype; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
D015703:Antigens, CD; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
Lymphome pagétoïde type Ketron-Goodman.